Association Between Acrylamide Exposure and the Odds of Developmental Disabilities in Children: A Cross-sectional Study

Overview

Journal Front Public Health

Specialty Public Health

Date 2022 Oct 17

PMID 36249258

Authors

Fanchao Meng

Yanjie Qi

YuanZhen Wu

Fan He

Affiliations

Soon will be listed here.

Abstract

Background: The association between acrylamide exposure and the odds of developmental disabilities (DDs) is unclear. We conducted this analysis to explore whether acrylamide exposure is related to DDs.

Methods: We analyzed a sample of 1,140 children aged 6-17 years old from the US National Health and Nutrition Examination Survey 2013-2014 to 2015-2016. DDs were determined by reports of parents. Acrylamide exposure was evaluated by the hemoglobin adducts of acrylamide (HbAA) and its major metabolite glycidamide (HbGA). We investigated the association using binomial logistic regression analysis by taking HbAA and HbGA as continuous or quartile variables. Restricted cubic splines (RCS) were used to explore the non-linear relationship between HbAA or HbGA and the odds of DDs. Interaction analysis and propensity score matching (PSM) were used to validate the results.

Results: A total of 134 participants were reported to have DDs. The median level of HbAA and HbGA was 41.6 and 40.5 pmol/g Hb, respectively. HbAA and HbGA were not associated with the odds of DDs when taken as continuous variables. When divided into quartiles, there was no evidence for a linear trend for HbAA and HbGA. RCS showed that there was a J-shaped association between HbGA and the odds of DDs ( for non-linearity, 0.023). The results were consistent in interaction analysis by age, gender, and race, and after PSM.

Conclusion: HbGA level was associated with the odds of DDs in a J-shaped manner among children. Further investigation is warranted to determine the causality and underlying mechanisms.

Citing Articles

Relationship of weight-adjusted waist index and developmental disabilities in children 6 to 17 years of age: a cross-sectional study.

Li X, Zhou Q Front Endocrinol (Lausanne). 2024; 15:1406996.

PMID: 39027477 PMC: 11254689. DOI: 10.3389/fendo.2024.1406996.

Association between the Healthy Eating Index-2015 and Developmental Disabilities in Children: A Cross-Sectional Analysis.

Gui J, Wang L, Han Z, Ding R, Yang X, Yang J Brain Sci. 2023; 13(9).

PMID: 37759954 PMC: 10526872. DOI: 10.3390/brainsci13091353.

Common Chemical Pollutants Causing a Lot of Ill Health.

Pizzorno J Integr Med (Encinitas). 2023; 21(5):8-12.

PMID: 36643211 PMC: 9831131.

References

Wagner-Schuman M, Richardson J, Auinger P, Braun J, Lanphear B, Epstein J . Association of pyrethroid pesticide exposure with attention-deficit/hyperactivity disorder in a nationally representative sample of U.S. children. Environ Health. 2015; 14:44. PMC: 4458051. DOI: 10.1186/s12940-015-0030-y. View

Huang M, Jiao J, Wang J, Chen X, Zhang Y . Associations of hemoglobin biomarker levels of acrylamide and all-cause and cardiovascular disease mortality among U.S. adults: National Health and Nutrition Examination Survey 2003-2006. Environ Pollut. 2018; 238:852-858. DOI: 10.1016/j.envpol.2018.03.109. View

Quan W, Li M, Jiao Y, Zeng M, He Z, Shen Q . Effect of Dietary Exposure to Acrylamide on Diabetes-Associated Cognitive Dysfunction from the Perspectives of Oxidative Damage, Neuroinflammation, and Metabolic Disorders. J Agric Food Chem. 2022; 70(14):4445-4456. DOI: 10.1021/acs.jafc.2c00662. View

Pelucchi C, Galeone C, Levi F, Negri E, Franceschi S, Talamini R . Dietary acrylamide and human cancer. Int J Cancer. 2005; 118(2):467-71. DOI: 10.1002/ijc.21336. View

Liu Z, Tse L, Chen B, Wu S, Chan D, Kowk T . Dietary acrylamide exposure was associated with mild cognition decline among non-smoking Chinese elderly men. Sci Rep. 2017; 7(1):6395. PMC: 5527102. DOI: 10.1038/s41598-017-06813-9. View

Hogervorst J, Saenen N, Nawrot T . Gestational acrylamide exposure and biomarkers of fetal growth: Probing the mechanism underlying the association between acrylamide and reduced fetal growth. Environ Int. 2021; 155:106668. DOI: 10.1016/j.envint.2021.106668. View

Yuan J, Li M, Lu Z . Racial/Ethnic Disparities in the Prevalence and Trends of Autism Spectrum Disorder in US Children and Adolescents. JAMA Netw Open. 2021; 4(3):e210771. PMC: 7936258. DOI: 10.1001/jamanetworkopen.2021.0771. View

Lindeman B, Johansson Y, Andreassen M, Husoy T, Dirven H, Hofer T . Does the food processing contaminant acrylamide cause developmental neurotoxicity? A review and identification of knowledge gaps. Reprod Toxicol. 2021; 101:93-114. DOI: 10.1016/j.reprotox.2021.02.006. View

. Developmental disabilities among children younger than 5 years in 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Glob Health. 2018; 6(10):e1100-e1121. PMC: 6139259. DOI: 10.1016/S2214-109X(18)30309-7. View

10.

Matoso V, Bargi-Souza P, Ivanski F, Romano M, Romano R . Acrylamide: A review about its toxic effects in the light of Developmental Origin of Health and Disease (DOHaD) concept. Food Chem. 2019; 283:422-430. DOI: 10.1016/j.foodchem.2019.01.054. View

11.

Zhan Y, Xiao Y, Guan T, Zhang S, Jiang Y . Relationship between gestational acrylamide exposure and offspring's growth: a systematic review and meta-analysis of cohort studies. Public Health Nutr. 2020; 23(10):1791-1799. PMC: 10200512. DOI: 10.1017/S1368980019005123. View

12.

Vesper H, Caudill S, Osterloh J, Meyers T, Scott D, Myers G . Exposure of the U.S. population to acrylamide in the National Health and Nutrition Examination Survey 2003-2004. Environ Health Perspect. 2010; 118(2):278-83. PMC: 2831930. DOI: 10.1289/ehp.0901021. View

13.

Koger S, Schettler T, Weiss B . Environmental toxicants and developmental disabilities: a challenge for psychologists. Am Psychol. 2005; 60(3):243-55. DOI: 10.1037/0003-066X.60.3.243. View

14.

Ogawa B, Ohishi T, Wang L, Takahashi M, Taniai E, Hayashi H . Disruptive neuronal development by acrylamide in the hippocampal dentate hilus after developmental exposure in rats. Arch Toxicol. 2010; 85(8):987-94. DOI: 10.1007/s00204-010-0622-9. View

15.

Zhang Y, Huang M, Zhuang P, Jiao J, Chen X, Wang J . Exposure to acrylamide and the risk of cardiovascular diseases in the National Health and Nutrition Examination Survey 2003-2006. Environ Int. 2018; 117:154-163. DOI: 10.1016/j.envint.2018.04.047. View

16.

Rice J . The carcinogenicity of acrylamide. Mutat Res. 2005; 580(1-2):3-20. DOI: 10.1016/j.mrgentox.2004.09.008. View

17.

Dybing E, Sanner T . Risk assessment of acrylamide in foods. Toxicol Sci. 2003; 75(1):7-15. DOI: 10.1093/toxsci/kfg165. View

18.

Loomes R, Hull L, Mandy W . What Is the Male-to-Female Ratio in Autism Spectrum Disorder? A Systematic Review and Meta-Analysis. J Am Acad Child Adolesc Psychiatry. 2017; 56(6):466-474. DOI: 10.1016/j.jaac.2017.03.013. View

19.

Kjuus H, Goffeng L, Heier M, Sjoholm H, Ovrebo S, Skaug V . Effects on the peripheral nervous system of tunnel workers exposed to acrylamide and N-methylolacrylamide. Scand J Work Environ Health. 2004; 30(1):21-9. DOI: 10.5271/sjweh.761. View

20.

Semla M, Goc Z, Martiniakova M, Omelka R, Formicki G . Acrylamide: a common food toxin related to physiological functions and health. Physiol Res. 2016; 66(2):205-217. DOI: 10.33549/physiolres.933381. View